ABT241129P123000
- 0.00
- 0.000.00%
Abbott Laboratories Newsroom
Abbott Tests New Balloon-Expandable TAVI System for Aortic Stenosis, Launches First Patient Procedures With Investigational TAVI Device
Express News | Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable Tavi System to Treat Aortic Stenosis
Abbott Announces First Step Toward Its Software-Guided Balloon-Expandable TAVI System to Treat Aortic Stenosis
Abbott Laboratories (NYSE:ABT) Is Largely Controlled by Institutional Shareholders Who Own 78% of the Company
WHO Extends Mpox Emergency; Canada Reports First Clade I Case
Trump Nominates Marty Makary For FDA Commissioner
Trump Picks Surgeon Makary to Head FDA, Rep. Dave Weldon to Lead CDC
Weekly Buzz: Nvidia Falls on Near Perfect Report, but Only For a Day
Market Climbs, Bitcoin Close to $100k | Live Stock
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Bitcoin Hits $99k, Thursday Market Whiplash Following Nvidia Price | Wall Street Today
Optimism Over Global Healthcare Sector Rises: Jefferies
Bitcoin Hits $98k, Nvidia Falls on Forward Guidance, Google Chrome Break-Up | Live Stock
MACH Alliance Expands Education Program, Appoints Dylan Valade of Abbott As Head of Education
Nvidia Forward Guidance Was Not Perfect, Market Flat | Wall Street Today
Unusual Options Activity: MET, CNH and Others Attract Market Bets, MET V/OI Ratio Reaches 318.2
Market Falls on Retail Results, Bitcoin Swells, All Eyes on Nvidia | Live Stock
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Express News | Insulet Announces Omnipod® 5 System Is Now Compatible With Abbott’s Freestyle Libre 2 Plus Sensor in the U.S.
Wells Fargo Maintains Abbott Laboratories(ABT.US) With Buy Rating, Maintains Target Price $133